Primary CNS Lymphoma Treatment (PDQ®)–Health Professional Version

SECTIONS

Changes to This Summary (01/05/2017)

The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.

General Information About Primary Central Nervous System (CNS) Lymphoma

Added text to the list of poor prognostic factors for primary CNS lymphoma to include intraocular disease and concomitant brain involvement (cited Kreher et al. as reference 6).

Treatment Option Overview for Primary CNS Lymphoma

An editorial change was made to this section.

This summary is written and maintained by the PDQ Adult Treatment Editorial Board, which is editorially independent of NCI. The summary reflects an independent review of the literature and does not represent a policy statement of NCI or NIH. More information about summary policies and the role of the PDQ Editorial Boards in maintaining the PDQ summaries can be found on the About This PDQ Summary and PDQ® - NCI's Comprehensive Cancer Database pages.

< Previous section
Key References for Primary CNS Lymphoma Treatment

Next section >
About This PDQ Summary